Alan W. Dunton

Alan W. Dunton, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Palatin Technologies Inc, CorMedix Inc. and Oragenics Inc. Over a trading history stretching from 16 February 2016 to 26 January 2026, the count stands at 37 filings.

In open-market terms, that means 10 purchases worth €3.5M on one side and 3 sales worth €1,035 on the other. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 21 share grants and 3 option exercises.

Half of the purchases are above €5,187 and half below. Of 7 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 27 January 2026, reports a share grant in CorMedix Inc. The clock since the last published purchase (17 June 2025) now reads 491 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.